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Abstract
Objectives: A database of patients operated of lung cancer was analyzed to evaluate the predictive risk factors of operative deaths and
life-threatening cardiopulmonary complications. Methods: From 1990 to 1997, data were collected concerning 634 consecutive patients
undergoing lung resection for non-small cell carcinoma in an academic medical centre and a regional hospital. Operations were managed by
a team of experienced surgeons, anaesthesiologists and chest physicians. Operative mortality was defined as death within 30 days of
operation and/or intra-hospital death. Respiratory failure, myocardial infarct, heart failure, pulmonary embolism and stroke were considered
as major non-fatal complications. Preoperative risk factors, extent of surgery, pTNM staging, perioperative mortality and major cardio-
pulmonary complications were recorded and evaluated using chi-square statistics and multivariate logistic regression. Results: Complete
data were obtained in 621 cases. The overall operative mortality was 3.2% (n = 19). Cardiovascular complications (n = 10), haemorrhage
(n = 4) and sepsis or acute lung injury (n = 5) were incriminated as the main causative factors. In addition, there were 13 life-threatening
complications (2.1%) consisting in strokes (n = 4), myocardial infarcts (n = 5), pulmonary embolisms (n = 1), acute lung injury (n = 1)
and respiratory failure (n = 2). Four independent predictors of operative death were identified: pneumonectomy, evidence of coronary
artery disease (CAD), ASA class 3 or 4 and period 1990–93. In addition, the risk of major complications was increased in hypertensive
patients and in those belonging to ASA class 3 or 4. A trend towards improved outcome was observed during the second period, from 1994
to 97. Conclusion: Our data demonstrate that perioperative mortality is mainly dependent on the extent of surgery, the presence of CAD
and provision of adequate medical and nursing care. Preoperative testing and interventions to reduce the cardiovascular risk factors may
help to further improve perioperative outcome. Ó 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Lung cancer represents a major problem, it is the most
common cause of cancer death in Western countries [1].
After diagnosis, survival is poor for all treatments except
when surgical resection is possible: more than 25% of oper-
ated patients will survive for 5 years [2]. Long-term prog-
nosis is largely determined by histologic findings, the
anatomic extent of the tumoural process and the complete-
ness of the surgical resection [3,4].
Over the last decades, life expectancy in developed
countries has increased far beyond 70 years. Accurate sta-
ging and the combination of neoadjuvant therapy with sur-
gical resection meet the need to treat a large variety of
patients with lung cancer, including elderly and chron-
ically ill patients with severe pathophysiologic alterations
[4].
Operative mortality ranges from 1 to 12% and is mainly
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related to the presence of intercurrent illness, to the patient’s
general condition, postoperative infection and uncontrolled
haemorrhage [5,6]. In addition, a wide spectrum of post-
operative cardiopulmonary complications may also occur
in as much as 30–60% of patients [7]. Therefore, improve-
ment of patient’s survival and quality of life following lung
resection can be achieved through identification of operative
risk factors, accurate staging, selection of the most appro-
priate therapy and high quality perioperative medical care.
In this article, we report 30-day mortality, major non-fatal
cardiopulmonary complications and their risk factors in 621
consecutive patients operated for lung cancer.
2. Methods
2.1. Patient selection
From January 1, 1990 to December 31, 1997, 634 con-
secutive patients underwent thoracic surgery for non-small
cell carcinoma in two institutions: an academic medical
centre (Hoˆpital Universitaire de Gene`ve, HUG) and a regio-
nal hospital (Centre Valaisan de Pneumologie, CVP) that
covered an area with approximately 450 000 inhabitants. All
patients were operated by one of three surgeons specialized
in thoracic surgery, and they were managed by the same
team of experienced anaesthesiologists and chest physi-
cians.
Preoperative evaluation included a complete history, phy-
sical examination, blood cell count, biochemical profile,
chest roentgenogram, ECG, pulmonary function tests and
computed tomographic scan of the chest and abdomen. Dif-
ferential lung perfusion scans were performed in patients
with forced expiratory volume in 1 s lower than 80% of
predicted value. Patients with risk factors for coronary
artery disease or with low functional capacity were further
evaluated by transthoracic echocardiography, stress testing
(maximal exercise or thallium-dipyridamole myocardial
scintigraphy) or coronary angiogram.
2.2. Operative procedures and anaesthesia management
The operations were performed through a standard pos-
terior-lateral or an anterior mini-thoracotomy and were
divided into pneumonectomy, lobectomy, lesser resection
(segmentectomy, partial or wedge resection) and explora-
tive thoracotomy. Prophylactic antibiotic (cefuroxime 1.5 g/
8 h, for 1 or 2 days) was given routinely and, after the
induction of anaesthesia, a double-lumen tube was inserted
for one-lung ventilation. At the end of surgery, all patients
were successfully extubated and were monitored for 24–48
h in an intermediate care unit. Epidural analgesia was pro-
vided in 82% of patients, for 48–96 h after surgery. Over the
last 4-year period (1994–1997), preoperative preparation
and postoperative recovery program were reinforced includ-
ing routine chest physiotherapy, early mobilization and oral
feeding as well as more intense analgesic regimen with
continuous administration of opiate and local anaesthetics.
2.3. Data collection
Data were extracted from the medical and nursing files.
Retrospective review was conducted until September 1992
in one centre (CVP) and until November 1994 in the other
(HUG); thereafter data were prospectively recorded. Infor-
mation were gathered concerning 20 items including demo-
graphic, clinical, functional, surgical and pathological
variables. Binary data were obtained by identification of
the presence or absence of relevant co-morbidities. The
diagnosis of coronary artery disease (CAD) was based on
a positive history of myocardial infarct or angina pectoris,
typical Q waves on the electrocardiogram, positive stress
test or evidence of coronary artery stenosis on the angio-
gram. Elevated blood pressure requiring chronic antihyper-
tensive treatment and diabetes mellitus treated with insulin
or oral hypoglycaemic medications were considered signif-
icant co-morbidities. The following cut-off points were
selected for age ( ‡ 70 years), body mass index ( ‡ 30),
renal function (serum creatinin .160 mg/dl), pulmonary
function (forced expiratory volume in 1 s, FEV1, less than
60% of predicted values), haemoglobin level ( £ 9 g/dl in
female and £ 10 g/dl in male) and operation duration
(‡ 160 min). The 5-grade classification of the American
Society Anaesthesiology (ASA) was used as a composite
index of the patient’s general status [8]. Lung cancer was
classified according to histological diagnosis, staging (I, II,
IIIa, IIIb and IV) and surgical resection. The pTNM scoring
system published in 1986 by the American Joint Committee
on Cancer International Classification and partially modi-
fied in 1992 was used for staging of bronchogenic tumours.
Operative mortality was defined as any death occurring
within 30 days of operation or after 30 days, in patients who
remained in the hospital since the time of operation.
Non-fatal life-threatening cardiopulmonary events occur-
ring within the first 30-postoperative days were defined as
major complications, if pharmacological or technical sup-
port was required, permanent disability ensued or if life
expectancy was threatened. Major respiratory morbidity
was considered if re-intubation and mechanical ventilation
for longer than 24 h was required; acute lung injury was
defined as diffuse pulmonary oedema, without cardiac
causes and with low oxygenation index (PaO2/FIO2 lower
than 300 mmHg). Pulmonary thromboembolism, heart fail-
ure (requiring the administration of vasoactive drugs), acute
myocardial infarct and stroke were also recorded. Bronch-
opleural fistula and prolonged air-leaks were not considered.
2.4. Statistical analysis
We studied the possible contribution to mortality and
major morbidity of demographic, clinical, functional, surgi-
cal and pathological variables, as well as of the operating
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centre and the year of operation. In univariate analysis, the
significance of each factor was evaluated using the x2 test
for categorical variables. Most of the variables were also
tested by Spearman rank (non-parametric) correlation ana-
lysis to determine whether the potential risk factors were
truly independent variables. Factors with an univariate sig-
nificance level of P , 0.25 were initially included as in-
dependent variables and multivariate logistic regression
analysis was used.
3. Results
Over an 8-year period, from 1990 to 1997, complete
information on all 20 items was obtained in 621 patients:
434 were operated in the academic centre (HUG) and 187 in
the regional centre (CVP). There were 437 men (80%) and
184 women (20%) with a mean age of 62 years ( – 9, standard
deviation) and 59 years ( – 12), respectively. Squamous cell
carcinoma was the most common tumour (56%), followed
by adenocarcinoma (29%), large cell carcinoma (5%) and
bronchioalveolar carcinoma (4%). There was no significant
time-related change in histological diagnosis, risk factors
and surgical resection rate from 1990 to 1997.
For patients with resectable lung tumour, the 30-day
operative mortality rate was 3.2% (n = 19) and cardiovas-
cular complications (n = 10), haemorrhage (n = 4) and sep-
sis or acute lung injury (n = 5) were incriminated as the
main causative factors for deaths. There were 13 life-threa-
tening complications (2.1%) consisting in strokes (n = 4),
myocardial infarcts (n = 5), pulmonary embolisms (n = 1),
acute lung injury (n = 1) and respiratory failure requiring
re-intubation (n = 2). In addition, two operative deaths (sep-
sis, myocardial infarct) occurred among 34 patients in
whom lung resection could not been performed because of
unexpected cancer extension (explorative thoracotomy).
Statistical univariate analysis demonstrated that mortality
was related to the type of surgical procedure, the year of
operation, the presence of CAD, ASA score and pTNM
staging (Tables 1and 2). Mortality rate was increased in
patients undergoing pneumonectomy (7.9%) and explora-
tive thoracotomy (5.9%) compared with those undergoing
lobectomy (1.2%) or lesser resection (2%). Gender, histo-
logical diagnosis, and surgical centre were not significantly
associated with perioperative mortality. The ASA classifi-
cation was correlated with the presence of CAD (R = 0.5,
P , 0.01) and with chronic obstructive pulmonary disease
(R = 0.4, P , 0.05). Multivariate analysis identified four
independent predictors of perioperative death: pneumonect-
omy, CAD, ASA class 3 or 4 and period 1990–93 (Fig. 1).
For non-fatal cardiorespiratory complications, advanced
age, presence of hypertension, ASA classification and year
of operation (period 1990–93) were considered as signifi-
cant risk factors by univariate analysis. In the final logistic
regression model, the risk of major complications was
increased independently during the early period 1990–93,
in hypertensive patients and in those belonging to ASA class
3 or 4 (Fig. 1). All potential risk factors together accounted
for 22% of the fatality rate and 18% of major cardiopulmon-
ary complications (R2 by multiple regression).
4. Discussion
Among 621 patients operated for non-small cell lung
cancer, we found that cardiovascular, septic and haemor-
rhage complications were mainly implicated as causative
factors in the 3.2% operative mortality rate. The risk of
death was significantly increased after pneumonectomy or
exploratory thoracotomy and in patients with coronary
artery disease. In addition, arterial hypertension was an
independent risk factor for the occurrence of life-threaten-
ing cardiopulmonary complications and a high ASA score
(3–4) was a simple and valuable preoperative risk factor for
an unfavourable outcome.
The overall mortality rate of 3.2% is comparable with
results reported in longitudinal studies from North America
and Western Europe [9–16]. However, direct comparison
between studies should be interpreted cautiously due to dif-
Table 1
Univariate analysis of preoperative risk factors for thirty-day mortality
among 621 patients undergoing thoracotomy
Variable N Mortality
(%)
P-value
Hospital
HUG 434 3.7 n.s.
CVP 187 2.7
Year of operation
1990–93 288 4.8 0.06
1994–97 333 2.1
Gender
Male 433 3.8 n.s.
Female 188 2.0
Age ‡ 70 years 188 3.6 n.s.
Obesity
Body mass index ‡ 30 35 4.8 n.s.
Coronary artery disease 76 7.9 ,0.01
Hypertension 188 3.9 n.s.
Arrhythmia 72 3.9 n.s.
Peripheral vascular disease 80 4.4 n.s.
Cardiac insufficiency
NYHA class 3 and 4 38 4.2 n.s.
Diabetes mellitus 81 3.7 n.s.
Chronic obstructive pulmonary disease
FEV1 £ 60% or FEV1/FVC £ 60% 89 4.8 n.s.
Renal dysfunction
Creatinin ‡ 160 mg/dl 17 0 n.s.
Anaemia
(Hb , 9 for female or
10 g/dl for male)
35 0 n.s.
ASA score
Class 3 and 4 235 6.4 ,0.01
NYHA, New York Heart Association; ASA, American Society of Anesthe-
siology physical status; FEV1, forced expiratory volume in 1 s; FVC,
forced vital capacity.
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ferences in definitions, duration of observation, type of sur-
gery, presence of co-morbidities and referral to high-or low-
volume hospitals (Table 3). In the present report, any death
was reported during the ‘in-hospital’ and/or within ‘30-day
after operation’ and therefore yields higher mortality rate
than when only considering either in-hospital or 30-day
mortality.
With regard to postoperative morbidity, we believe that
all complications should not be analyzed together as one
group since they are not equivalent. For instance, atelectasis
or myocardial ischaemia are less clinically relevant than
respiratory failure, sepsis or myocardial infarct, that in
turn are less clinically significant than death. Therefore,
we limited our analysis to the most severe and binary peri-
operative outcome data, i.e. death and major cardiopulmon-
ary complications.
In a retrospective series including 1076 consecutive
patients operated between 1978 and 1984, Deslauriers et
al. [11] reported 9.8% major non-fatal complications and
3.2% operative deaths that were related to higher stage of
cancer, extended lung resection, advanced age, low forced
expiratory volume, weigh loss and coexisting disease. In the
present study, age was not considered as an independent risk
factor after adjustment for concomitant morbidities.
Furthermore, recent improvements in patient preparation
and management have likely contributed to reduce the risk
of major complications and deaths.
The extent of surgery is a well-recognized risk factor and,
mortality rate ranging 3–17% following pneumonectomy
and 1–10% after lesser resections have been reported
(Table 3). Compared with earlier data, the main causes of
deaths have now shifted from respiratory failure and
bronchopleural fistula to cardiovascular disorders such as
myocardial infarct, arrhythmia’s and pulmonary emboli
[6,11]. In addition to the extent of surgery, we identified
ASA classes 3 and 4, and coronary artery disease as inde-
pendent risk factors for death. Several scoring indexes have
been proposed to address the severity of illness and prog-
nostic stratification after major surgery, but few studies have
dealt specifically with thoracic surgery [17]. In a prospec-
tive trial including 180 patients undergoing lung surgery,
Melendez et al. [17] failed to confirm the validity of a multi-
factorial cardiopulmonary risk index to predict postopera-
tive outcome. Scoring ASA physical status is commonly
used for operative risk stratification by anaesthesiologists,
and this simple composite index incorporates several pre-
operative risk factors such as age, cardiac, respiratory,
renal and neurologic disorders as well as nutritional status
[8].
Table 2
Univariate analysis of surgical factors and staging evaluation for 30-day
mortality among 621 patients undergoing thoracotomy
Variable N Mortality (%) P-value
Type of surgery ,0.05
Pneumonectomy 151 7.9
Lobectomy 328 1.2
Bi-lobectomy 33 3.0
Lesser resection 75 2.7
Exploratory thoracotomy 34 5.9
Duration of surgery
‡ 200 min 240 3.6 n.s.
PTNM Stage ,0.05
Stage I 335 1.5
Stage II 174 4.0
Stage IIIa 93 7.5
Stage IIIb and IV 19 5.3
Fig. 1. Independent risk factors for operative mortality and life-threatening cardiorespiratory complications.
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Since CAD is a predictor of operative death and that
cardiac disorders are the main causes of death, patients
with cardiovascular risk factors should be screened for the
presence of CAD before elective lung resection. In agree-
ment with the guidelines of the American College of Car-
diology, patients with unstable angina pectoris or recent
myocardial infarct should undergo coronary catheterization,
whereas a Thallium-dipyridamole myocardial scintigraphy
is advocated in those patients with diabetes, peripheral vas-
cular diseases or impaired functional status [18]. Whenever
possible, in case of significant coronary artery stenosis, per-
cutaneous angioplasty can be performed 1–2 weeks before
thoracotomy or coronary artery bypass surgery can be com-
bined at the time of lung resection or performed 2–3 weeks
earlier [19].
In addition to routine investigations and the ‘flight of
stairs’ test, measurement of the diffusing capacity to carbon
monoxide (Dlco) and maximal oxygen uptake during exer-
cise (VO2max) have been proposed to identify those patients
with low cardiopulmonary reserve capacity [20,21]. A pre-
dicted postoperative Dlco below 60% of predicted values
and preoperative VO2max below 43% of predicted values
are highly predictive of postoperative cardiopulmonary
complications and likely contraindicate resections invol-
ving more than one lobe. A controversial debate surrounds
this issue and our data support the view that patients should
not be denied surgical treatment on the exclusive basis of
advanced age or a single abnormal functional test. Others
have demonstrated that patients with borderline pulmonary
function have minimal decrease or may even improve post-
operatively, and that elderly patients could benefit from a
curative surgical resection with an acceptable risk of early
complications [22,23].
Interestingly, we observed lower perioperative mortality
and morbidity rates during the period 1994–97 versus
1990–93, which could result from improvements in patient
selection and preparation, operative techniques, and better
postoperative control of pain and infection. Over recent
years, there has been greater interest in lesser invasive sur-
gical approach and better understanding of the physiologic
changes associated with thoracotomy. In our group, anterior
mini-thoracotomies have been performed routinely and epi-
dural analgesic regimen have been used more frequently
during the last 4 years. Although studies do not show mea-
surable differences in pulmonary function, continuous epi-
dural analgesia without undesirable sedation allows the
patient to take deeper breaths and may decrease the risk
of deep vein thrombosis and pulmonary embolism [24]. It
is well recognized that preoperative pulmonary preparation,
including the use of physiotherapy, exercise training,
bronchodilators and antibiotic therapy can reduce the risk
of postoperative infection [25].
Knowledge of risk factors for operative mortality as well
as long-term survival in patients with lung cancer is useful
for several reasons. First, the medical team will be able to
weigh the risk of the operative procedure against the risk of
death from an untreated or partially resected lesion, keeping
in mind that surgery offers the only real chance of cure in
non-small cell lung cancer. Second, patients considered to
be at higher cardiopulmonary risk might deserve aggressive
perioperative medical management including preoperative
respiratory training, cardiovascular monitoring with transe-
sophageal echocardiography and right heart catheterization,
as well as a planned postoperative admission in a high-
dependency unit. Alternatively, lesser invasive procedures
or non-surgical alternatives could also be proposed in
selected high-risk cases. Third, postoperative outcome
data and assessment of their risk factor provide the basis
for quality control management in a single institution and
comparison of therapeutic strategies with other institutions.
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Appendix A Conference discussion
Dr P. Kappetein (Leiden, The Netherlands): We did a study in almost
the same period as you showed us, from 1990 to 1995, and we did it in
three different centres. You also had different centres included. Did you
see any difference between the centres?
Dr. de Perrot: No, we haven’t seen any difference between the centres.
It was the same conclusion.
Dr T. Dosios (Athens, Greece): You’ve found that coronary artery
disease is one of the main risk factors for your patients. How vigorous
are you in deciding which patients have coronary artery disease? Do you
depend just on the history, e.g. if the patient has angina, or on his plain
ECG, or do you perform an exercise test, or coronary arteriogram? How
vigorous are you for checking, for examining, the coronary arteries of your
patients?
Dr de Perrot: Initial assessment is based on the clinical history and
ECG. If the patient gets angina, if he has arterial disease or if he has
diabetes, we will do a thallium scintigraphy. If the thallium is picking
up for coronary artery disease, then we will do a coronary angiography.
But at first, we will do a thallium assessment.
Otherwise, if the patient has unstable angina or previous infarct of the
myocardium, we will do a coronary angiography instead of a thallium
scintigraphy.
Dr J Hasse (Freiburg, Germany): How many cases had occult coronary
artery disease? If one knows about it one would take special care of the
patient, monitor him more intensively and get him safely oxygenated all
the time. The most dangerous thing is not to be aware of coronary artery
disease. We sometimes see patients who are asymptomatic, have a normal
ECG, and still have severe coronary artery disease. How many cases in
your series had occult ischaemic heart disease?
Dr de Perrot: I don’t exactly remember the number, but the number
wasn’t really high. The percentage of patients who presented with a heart
problem were about ten out of the whole study. So the number of patients
who had undetected coronary disease prior to surgery was really low, but I
don’t have the exact number.
Dr J.-F. Velly (Pessac, France): Do you do necropsy to assess that your
patients were dead from coronary diseases?
Dr de Perrot: Yes, we have done necropsy in most of the patients who
died during the operative/perioperative phase.
Dr Hasse: May I comment and ask you on a second detail of your
review. You stated a mortality rate of 5.6% in the exploratory thoraco-
tomies, which is similar to an own study, as the second highest ranking
mortality behind pneumonectomy. Would you suggest that an incomplete
resection instead of exploratory thoracotomy could lead to a better out-
come? Have you been looking closer to those cases for the reason of a
mere exploration?
Dr de Perrot: Most of these cases were exploratory thoracotomy
because of the diffuse disease. In a previous series where we looked
over the last 20 years, we had the same consideration, that the operative
mortality in patients undergoing exploratory thoracotomy was relatively
high. Therefore, this high mortality likely resulted from the extended dis-
section before assessment of the non-resectability of the tumour.
.
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